世界のデジタルコンパニオン診断市場インサイト及び予測(~2026年)

【英語タイトル】Global Digital Companion Diagnostics Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV11654)・商品コード:QYR20NV11654
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:90
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはデジタルコンパニオン診断の世界市場について調査・分析した資料です。種類別(ポリメラーゼ連鎖反応(PCR)、免疫組織化学(IHC)、in situハイブリダイゼーション(ISH)、次世代シーケンシング(NGS))の市場規模、用途別(病院、製薬会社、研究所、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別デジタルコンパニオン診断の競争状況、市場シェア
・世界のデジタルコンパニオン診断市場:種類別市場規模 2015年-2020年(ポリメラーゼ連鎖反応(PCR)、免疫組織化学(IHC)、in situハイブリダイゼーション(ISH)、次世代シーケンシング(NGS))
・世界のデジタルコンパニオン診断市場:種類別市場規模予測 2021年-2026年(ポリメラーゼ連鎖反応(PCR)、免疫組織化学(IHC)、in situハイブリダイゼーション(ISH)、次世代シーケンシング(NGS))
・世界のデジタルコンパニオン診断市場:用途別市場規模 2015年-2020年(病院、製薬会社、研究所、その他)
・世界のデジタルコンパニオン診断市場:用途別市場規模予測 2021年-2026年(病院、製薬会社、研究所、その他)
・北米のデジタルコンパニオン診断市場分析:米国、カナダ
・ヨーロッパのデジタルコンパニオン診断市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのデジタルコンパニオン診断市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のデジタルコンパニオン診断市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのデジタルコンパニオン診断市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Roche Holdings (Switzerland)、Abbott Laboratories (US)、Thermo Fisher Scientific (US)、Agilent Technologies (US)、Life Technologies (US)、GE Healthcare (UK)、Agendia (Angola)、Qiagen (Germany)、Genomic Health (US)、Myriad Genetics (US)、Advanced Cell Diagnostics (US)、Danaher (US)、Applied Proteomics (US)
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Digital Companion Diagnostics Market
The global Digital Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Digital Companion Diagnostics Scope and Market Size
Digital Companion Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Digital Companion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Roche Holdings (Switzerland)
Abbott Laboratories (US)
Thermo Fisher Scientific (US)
Agilent Technologies (US)
Life Technologies (US)
GE Healthcare (UK)
Agendia (Angola)
Qiagen (Germany)
Genomic Health (US)
Myriad Genetics (US)
Advanced Cell Diagnostics (US)
Danaher (US)
Applied Proteomics (US)

Market segment by Type, the product can be split into
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market segment by Application, split into
Hospitals
Pharmaceutical Companies
Laboratories
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Digital Companion Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Polymerase Chain Reaction (PCR)
1.4.3 Immunohistochemistry (IHC)
1.4.4 In Situ Hybridization (ISH)
1.4.5 Next Generation Sequencing (NGS)
1.5 Market by Application
1.5.1 Global Digital Companion Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Pharmaceutical Companies
1.5.4 Laboratories
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Digital Companion Diagnostics Market Perspective (2015-2026)
2.2 Global Digital Companion Diagnostics Growth Trends by Regions
2.2.1 Digital Companion Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Digital Companion Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Digital Companion Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Digital Companion Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Digital Companion Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Digital Companion Diagnostics Players by Market Size
3.1.1 Global Top Digital Companion Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Digital Companion Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Digital Companion Diagnostics Market Concentration Ratio
3.2.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2019
3.3 Digital Companion Diagnostics Key Players Head office and Area Served
3.4 Key Players Digital Companion Diagnostics Product Solution and Service
3.5 Date of Enter into Digital Companion Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Digital Companion Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Digital Companion Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Digital Companion Diagnostics Market Size by Application (2015-2020)
5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Digital Companion Diagnostics Market Size (2015-2020)
6.2 Digital Companion Diagnostics Key Players in North America (2019-2020)
6.3 North America Digital Companion Diagnostics Market Size by Type (2015-2020)
6.4 North America Digital Companion Diagnostics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Digital Companion Diagnostics Market Size (2015-2020)
7.2 Digital Companion Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Digital Companion Diagnostics Market Size by Type (2015-2020)
7.4 Europe Digital Companion Diagnostics Market Size by Application (2015-2020)

8 China
8.1 China Digital Companion Diagnostics Market Size (2015-2020)
8.2 Digital Companion Diagnostics Key Players in China (2019-2020)
8.3 China Digital Companion Diagnostics Market Size by Type (2015-2020)
8.4 China Digital Companion Diagnostics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Digital Companion Diagnostics Market Size (2015-2020)
9.2 Digital Companion Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Digital Companion Diagnostics Market Size by Type (2015-2020)
9.4 Japan Digital Companion Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Digital Companion Diagnostics Market Size (2015-2020)
10.2 Digital Companion Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Digital Companion Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Digital Companion Diagnostics Market Size by Application (2015-2020)

11 India
11.1 India Digital Companion Diagnostics Market Size (2015-2020)
11.2 Digital Companion Diagnostics Key Players in India (2019-2020)
11.3 India Digital Companion Diagnostics Market Size by Type (2015-2020)
11.4 India Digital Companion Diagnostics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Digital Companion Diagnostics Market Size (2015-2020)
12.2 Digital Companion Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Digital Companion Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Digital Companion Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Roche Holdings (Switzerland)
13.1.1 Roche Holdings (Switzerland) Company Details
13.1.2 Roche Holdings (Switzerland) Business Overview
13.1.3 Roche Holdings (Switzerland) Digital Companion Diagnostics Introduction
13.1.4 Roche Holdings (Switzerland) Revenue in Digital Companion Diagnostics Business (2015-2020))
13.1.5 Roche Holdings (Switzerland) Recent Development
13.2 Abbott Laboratories (US)
13.2.1 Abbott Laboratories (US) Company Details
13.2.2 Abbott Laboratories (US) Business Overview
13.2.3 Abbott Laboratories (US) Digital Companion Diagnostics Introduction
13.2.4 Abbott Laboratories (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
13.2.5 Abbott Laboratories (US) Recent Development
13.3 Thermo Fisher Scientific (US)
13.3.1 Thermo Fisher Scientific (US) Company Details
13.3.2 Thermo Fisher Scientific (US) Business Overview
13.3.3 Thermo Fisher Scientific (US) Digital Companion Diagnostics Introduction
13.3.4 Thermo Fisher Scientific (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
13.3.5 Thermo Fisher Scientific (US) Recent Development
13.4 Agilent Technologies (US)
13.4.1 Agilent Technologies (US) Company Details
13.4.2 Agilent Technologies (US) Business Overview
13.4.3 Agilent Technologies (US) Digital Companion Diagnostics Introduction
13.4.4 Agilent Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
13.4.5 Agilent Technologies (US) Recent Development
13.5 Life Technologies (US)
13.5.1 Life Technologies (US) Company Details
13.5.2 Life Technologies (US) Business Overview
13.5.3 Life Technologies (US) Digital Companion Diagnostics Introduction
13.5.4 Life Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
13.5.5 Life Technologies (US) Recent Development
13.6 GE Healthcare (UK)
13.6.1 GE Healthcare (UK) Company Details
13.6.2 GE Healthcare (UK) Business Overview
13.6.3 GE Healthcare (UK) Digital Companion Diagnostics Introduction
13.6.4 GE Healthcare (UK) Revenue in Digital Companion Diagnostics Business (2015-2020)
13.6.5 GE Healthcare (UK) Recent Development
13.7 Agendia (Angola)
13.7.1 Agendia (Angola) Company Details
13.7.2 Agendia (Angola) Business Overview
13.7.3 Agendia (Angola) Digital Companion Diagnostics Introduction
13.7.4 Agendia (Angola) Revenue in Digital Companion Diagnostics Business (2015-2020)
13.7.5 Agendia (Angola) Recent Development
13.8 Qiagen (Germany)
13.8.1 Qiagen (Germany) Company Details
13.8.2 Qiagen (Germany) Business Overview
13.8.3 Qiagen (Germany) Digital Companion Diagnostics Introduction
13.8.4 Qiagen (Germany) Revenue in Digital Companion Diagnostics Business (2015-2020)
13.8.5 Qiagen (Germany) Recent Development
13.9 Genomic Health (US)
13.9.1 Genomic Health (US) Company Details
13.9.2 Genomic Health (US) Business Overview
13.9.3 Genomic Health (US) Digital Companion Diagnostics Introduction
13.9.4 Genomic Health (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
13.9.5 Genomic Health (US) Recent Development
13.10 Myriad Genetics (US)
13.10.1 Myriad Genetics (US) Company Details
13.10.2 Myriad Genetics (US) Business Overview
13.10.3 Myriad Genetics (US) Digital Companion Diagnostics Introduction
13.10.4 Myriad Genetics (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
13.10.5 Myriad Genetics (US) Recent Development
13.11 Advanced Cell Diagnostics (US)
10.11.1 Advanced Cell Diagnostics (US) Company Details
10.11.2 Advanced Cell Diagnostics (US) Business Overview
10.11.3 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Introduction
10.11.4 Advanced Cell Diagnostics (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
10.11.5 Advanced Cell Diagnostics (US) Recent Development
13.12 Danaher (US)
10.12.1 Danaher (US) Company Details
10.12.2 Danaher (US) Business Overview
10.12.3 Danaher (US) Digital Companion Diagnostics Introduction
10.12.4 Danaher (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
10.12.5 Danaher (US) Recent Development
13.13 Applied Proteomics (US)
10.13.1 Applied Proteomics (US) Company Details
10.13.2 Applied Proteomics (US) Business Overview
10.13.3 Applied Proteomics (US) Digital Companion Diagnostics Introduction
10.13.4 Applied Proteomics (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
10.13.5 Applied Proteomics (US) Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Digital Companion Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Digital Companion Diagnostics Revenue
Table 3. Ranking of Global Top Digital Companion Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Digital Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Polymerase Chain Reaction (PCR)
Table 6. Key Players of Immunohistochemistry (IHC)
Table 7. Key Players of In Situ Hybridization (ISH)
Table 8. Key Players of Next Generation Sequencing (NGS)
Table 9. Global Digital Companion Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Digital Companion Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Digital Companion Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Digital Companion Diagnostics Market Share by Regions (2015-2020)
Table 13. Global Digital Companion Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Digital Companion Diagnostics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Digital Companion Diagnostics Market Growth Strategy
Table 19. Main Points Interviewed from Key Digital Companion Diagnostics Players
Table 20. Global Digital Companion Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Digital Companion Diagnostics Market Share by Players (2015-2020)
Table 22. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Digital Companion Diagnostics as of 2019)
Table 23. Global Digital Companion Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Digital Companion Diagnostics Product Solution and Service
Table 26. Date of Enter into Digital Companion Diagnostics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Digital Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Digital Companion Diagnostics Market Size Share by Type (2015-2020)
Table 30. Global Digital Companion Diagnostics Revenue Market Share by Type (2021-2026)
Table 31. Global Digital Companion Diagnostics Market Size Share by Application (2015-2020)
Table 32. Global Digital Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Digital Companion Diagnostics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Digital Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Digital Companion Diagnostics Market Share (2019-2020)
Table 36. North America Digital Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 38. North America Digital Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 40. Europe Key Players Digital Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Digital Companion Diagnostics Market Share (2019-2020)
Table 42. Europe Digital Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 44. Europe Digital Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 46. China Key Players Digital Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Digital Companion Diagnostics Market Share (2019-2020)
Table 48. China Digital Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 49. China Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 50. China Digital Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 51. China Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 52. Japan Key Players Digital Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Digital Companion Diagnostics Market Share (2019-2020)
Table 54. Japan Digital Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 56. Japan Digital Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Digital Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Digital Companion Diagnostics Market Share (2019-2020)
Table 60. Southeast Asia Digital Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 62. Southeast Asia Digital Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 64. India Key Players Digital Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Digital Companion Diagnostics Market Share (2019-2020)
Table 66. India Digital Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 67. India Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 68. India Digital Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 69. India Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Digital Companion Diagnostics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Digital Companion Diagnostics Market Share (2019-2020)
Table 72. Central & South America Digital Companion Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 74. Central & South America Digital Companion Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 76. Roche Holdings (Switzerland) Company Details
Table 77. Roche Holdings (Switzerland) Business Overview
Table 78. Roche Holdings (Switzerland) Product
Table 79. Roche Holdings (Switzerland) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 80. Roche Holdings (Switzerland) Recent Development
Table 81. Abbott Laboratories (US) Company Details
Table 82. Abbott Laboratories (US) Business Overview
Table 83. Abbott Laboratories (US) Product
Table 84. Abbott Laboratories (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 85. Abbott Laboratories (US) Recent Development
Table 86. Thermo Fisher Scientific (US) Company Details
Table 87. Thermo Fisher Scientific (US) Business Overview
Table 88. Thermo Fisher Scientific (US) Product
Table 89. Thermo Fisher Scientific (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 90. Thermo Fisher Scientific (US) Recent Development
Table 91. Agilent Technologies (US) Company Details
Table 92. Agilent Technologies (US) Business Overview
Table 93. Agilent Technologies (US) Product
Table 94. Agilent Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 95. Agilent Technologies (US) Recent Development
Table 96. Life Technologies (US) Company Details
Table 97. Life Technologies (US) Business Overview
Table 98. Life Technologies (US) Product
Table 99. Life Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 100. Life Technologies (US) Recent Development
Table 101. GE Healthcare (UK) Company Details
Table 102. GE Healthcare (UK) Business Overview
Table 103. GE Healthcare (UK) Product
Table 104. GE Healthcare (UK) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 105. GE Healthcare (UK) Recent Development
Table 106. Agendia (Angola) Company Details
Table 107. Agendia (Angola) Business Overview
Table 108. Agendia (Angola) Product
Table 109. Agendia (Angola) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 110. Agendia (Angola) Recent Development
Table 111. Qiagen (Germany) Business Overview
Table 112. Qiagen (Germany) Product
Table 113. Qiagen (Germany) Company Details
Table 114. Qiagen (Germany) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 115. Qiagen (Germany) Recent Development
Table 116. Genomic Health (US) Company Details
Table 117. Genomic Health (US) Business Overview
Table 118. Genomic Health (US) Product
Table 119. Genomic Health (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 120. Genomic Health (US) Recent Development
Table 121. Myriad Genetics (US) Company Details
Table 122. Myriad Genetics (US) Business Overview
Table 123. Myriad Genetics (US) Product
Table 124. Myriad Genetics (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 125. Myriad Genetics (US) Recent Development
Table 126. Advanced Cell Diagnostics (US) Company Details
Table 127. Advanced Cell Diagnostics (US) Business Overview
Table 128. Advanced Cell Diagnostics (US) Product
Table 129. Advanced Cell Diagnostics (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 130. Advanced Cell Diagnostics (US) Recent Development
Table 131. Danaher (US) Company Details
Table 132. Danaher (US) Business Overview
Table 133. Danaher (US) Product
Table 134. Danaher (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 135. Danaher (US) Recent Development
Table 136. Applied Proteomics (US) Company Details
Table 137. Applied Proteomics (US) Business Overview
Table 138. Applied Proteomics (US) Product
Table 139. Applied Proteomics (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (Million US$)
Table 140. Applied Proteomics (US) Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Digital Companion Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Immunohistochemistry (IHC) Features
Figure 4. In Situ Hybridization (ISH) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Global Digital Companion Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Digital Companion Diagnostics Report Years Considered
Figure 12. Global Digital Companion Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Digital Companion Diagnostics Market Share by Regions: 2020 VS 2026
Figure 14. Global Digital Companion Diagnostics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Digital Companion Diagnostics Market Share by Players in 2019
Figure 17. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Digital Companion Diagnostics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Digital Companion Diagnostics Revenue in 2019
Figure 19. North America Digital Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Digital Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Digital Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Digital Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Digital Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Digital Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Digital Companion Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed


【掲載企業】

Roche Holdings (Switzerland)、Abbott Laboratories (US)、Thermo Fisher Scientific (US)、Agilent Technologies (US)、Life Technologies (US)、GE Healthcare (UK)、Agendia (Angola)、Qiagen (Germany)、Genomic Health (US)、Myriad Genetics (US)、Advanced Cell Diagnostics (US)、Danaher (US)、Applied Proteomics (US)

★調査レポート[世界のデジタルコンパニオン診断市場インサイト及び予測(~2026年)] (コード:QYR20NV11654)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のデジタルコンパニオン診断市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆